Pathogenetic Mechanisms of Diabetic Nephropathy
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Diabetes is the leading cause of ESRD because diabetic nephropathy develops in 30 to 40% of patients. Diabetic nephropathy does not develop in the absence of hyperglycemia, even in the presence of a genetic predisposition. Multigenetic predisposition contributes in the development of diabetic nephropathy, thus supporting that many factors are involved in the pathogenesis of the disease. Hyperglycemia induces renal damage directly or through hemodynamic modifications. It induces activation of protein kinase C, increased production of advanced glycosylation end products, and diacylglycerol synthesis. In addition, it is responsible for hemodynamic alterations such as glomerular hyperfiltration, shear stress, and microalbuminuria. These alterations contribute to an abnormal stimulation of resident renal cells that produce more TGF-beta1. This growth factor upregulates GLUT-1, which induces an increased intracellular glucose transport and D-glucose uptake. TGF-beta1 causes augmented extracellular matrix protein deposition (collagen types I, IV, V, and VI; fibronectin, and laminin) at the glomerular level, thus inducing mesangial expansion and glomerular basement membrane thickening. However, low enzymatic degradation of extracellular matrix contributes to an excessive accumulation. Because hyperglycemia is the principal factor responsible for structural alterations at the renal level, glycemic control remains the main target of the therapy, whereas pancreas transplantation is the best approach for reducing the renal lesions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378
Ohkubo, Y., Kishikawa, H., Araki, E., Miyata, T., Isami, S., Motoyoshi, S., Kojima, Y., Furuyoshi, N., & Shichiri, M. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01064-k · Cited by 3,079
Protein kinase C activation and the development of diabetic complications.
Koya, D., & King, G. L. (1998) · Diabetes · doi:10.2337/diabetes.47.6.859 · Cited by 1,330
Reversal of Lesions of Diabetic Nephropathy after Pancreas Transplantation
Fioretto, P., Steffes, M. W., Sutherland, D. E. R., Goetz, F. C., & Mauer, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807093390202 · Cited by 1,135
Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor
Ishii, H., Jirousek, M. R., Koya, D., Takagi, C., Xia, P., Clermont, A., Bursell, S.-E., Kern, T. S., Ballas, L. M., Heath, W. F., et al. (1996) · Science · doi:10.1126/science.272.5262.728 · Cited by 1,103
Familial Clustering of Diabetic Kidney Disease
Seaquist, E. R., Goetz, F. C., Rich, S., & Barbosa, J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905043201801 · Cited by 994
The Wisconsin Epidemiologic Study of Diabetic Retinopathy
Klein, R., Klein, B. E. K., Moss, S. E., Davis, M. D., & DeMets, D. L. (1984) · Ophthalmology · doi:10.1016/s0161-6420(84)34102-1 · Cited by 981
Effect of lipid reduction on the progression of renal disease: A meta-analysis
Fried, L. F., Orchard, T. J., & Kasiske, B. L. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00487.x · Cited by 672
Koya, D., Jirousek, M. R., Lin, Y. W., Ishii, H., Kuboki, K., & King, G. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119503 · Cited by 536
Bresnick, G. H. (1986) · Ophthalmology · doi:10.1016/s0161-6420(86)33650-9 · Cited by 410
Pettitt, D. J., Saad, M. F., Bennett, P. H., Nelson, R. G., & Knowler, W. C. (1990) · Diabetologia · doi:10.1007/bf00404096 · Cited by 393
Effect of Pravastatin on Cardiovascular Events in People With Chronic Kidney Disease
Tonelli, M., Isles, C., Curhan, G. C., Tonkin, A., Pfeffer, M. A., Shepherd, J., Sacks, F. M., Furberg, C., Cobbe, S. M., Simes, J., et al. (2004) · Circulation · doi:10.1161/01.cir.0000143892.84582.60 · Cited by 381
Sun, L., Halaihel, N., Zhang, W., Rogers, T., & Levi, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110650200 · Cited by 333
Pleiotropic Effects of Statins: Lipid Reduction and Beyond
McFarlane, S. I. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.4.1451 · Cited by 314
Wang, Z., Jiang, T., Li, J., Proctor, G., McManaman, J. L., Lucia, S., Chua, S., & Levi, M. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2328 · Cited by 303
Forbes, J. M., Thallas, V., Thomas, M. C., Founds, H. W., Burns, W. C., Jerums, G., & Cooper, M. E. (2003) · The FASEB Journal · doi:10.1096/fj.02-1102fje · Cited by 263
The role of angiotensin II in diabetic nephropathy: Emphasis on nonhemodynamic mechanisms
Wolf, G., & Ziyadeh, F. N. (1997) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(97)90023-8 · Cited by 236
The Familial Risk of End-Stage Renal Disease in African Americans
Freedman, B. I., Spray, B. J., Tuttle, A. B., & Buckalew, V. M. (1993) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80266-6 · Cited by 235
Bowden, D. W., Sale, M., Howard, T. D., Qadri, A., Spray, B. J., Rothschild, C. B., Akots, G., Rich, S. S., & Freedman, B. I. (1997) · Diabetes · doi:10.2337/diab.46.5.882 · Cited by 212
Proteomic analysis for the assessment of diabetic renal damage in humans
MISCHAK, H., KAISER, T., WALDEN, M., HILLMANN, M., WITTKE, S., HERRMANN, A., KNUEPPEL, S., HALLER, H., & FLISER, D. (2004) · Clinical Science · doi:10.1042/cs20040103 · Cited by 176
Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23
Vardarli, I., Baier, L. J., Hanson, R. L., Akkoyun, I., Fischer, C., Rohmeiss, P., Basci, A., Bartram, C. R., Van Der Woude, F. J., & Janssen, B. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00663.x · Cited by 165
The Wisconsin Epidemiologic Study of Diabetic Retinopathy-Reply
Klein, R. (1995) · Archives of Ophthalmology · doi:10.1001/archopht.1995.01100060024016 · Cited by 154
Arici, M., Chana, R., Lewington, A., Brown, J., & Brunskill, N. J. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000042167.66685.ea · Cited by 142
Paolo, S. D., Gesualdo, L., Ranieri, E., Grandaliano, G., & Schena, F. P. (1996) · Europe PMC (PubMed Central) · Cited by 133
Self-citationGruden, G., Zonca, S., Hayward, A. E., Thomas, S., Maestrini, S., Gnudi, L., & Viberti, G. C. (2000) · Diabetes · doi:10.2337/diabetes.49.4.655 · Cited by 127
Gruden, G., Thomas, S., Burt, D. J., Lane, S. J., Chusney, G. D., Sacks, S. H., & Viberti, G. C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.12112 · Cited by 121
Meier, M., Kaiser, T., Herrmann, A., Knueppel, S., Hillmann, M., Koester, P., Danne, T., Haller, H. G., Fliser, D., & Mischak, H. (2005) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2004.10.002 · Cited by 119
Heilig, C. W., Liu, Y., England, R. L., Freytag, S. O., Gilbert, J. D., Heilig, K. O., Zhu, M., Concepcion, L. A., & Brosius, F. C. (1997) · Diabetes · doi:10.2337/diab.46.6.1030 · Cited by 115
TGF-β1 stimulates glucose uptake by enhancing GLUT1 expression in mesangial cells
Inoki, K., Haneda, M., Maeda, S., Koya, D., & Kikkawa, R. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00438.x · Cited by 105
Kim, S. I., Han, D. C., & Lee, H. B. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v11180 · Cited by 97
GLUT-1 Overexpression: Link Between Hemodynamic and Metabolic Factors in Glomerular Injury?
Gnudi, L., Viberti, G., Raij, L. R., Rodriguez, V., Burt, D. J., Cortés, P., Hartley, B., Thomas, S., Maestrini, S., & Gruden, G. (2003) · Hypertension · doi:10.1161/01.hyp.0000075949.19968.ef · Cited by 95
Role of hyperlipidemia in progressive renal disease: Focus on diabetic nephropathy
Jandeleit-Dahm, K. A. M., Cao, Z., Cox, A. J., Kelly, D. J., Gilbert, R. E., & Cooper, M. E. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.07109.x · Cited by 91
Gesualdo, L., Ranieri, E., Monno, R., Rossiello, M. R., Colucci, M., Semeraro, N., Grandaliano, G., Schena, F. P., & Cerullo, G. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00578.x · Cited by 89
Self-citationApolipoprotein-B-Containing Lipoproteins and the Progression of Renal Insufficiency
Samuelsson, O. G., Aurell, M., Knight‐Gibson, C., Alaupovic, P., & Attman, P. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000187210 · Cited by 82
The role of protein kinase C in the development of the complications of diabetes
Ways, D. K., & Sheetz, M. J. (2000) · Vitamins and hormones · doi:10.1016/s0083-6729(00)60019-5 · Cited by 74
Linkage Analysis of Candidate Loci for End-Stage Renal Disease due to Diabetic Nephropathy
Iyengar, S. K., Fox, K. A., Schachere, M., Manzoor, F., Slaughter, M. E., Covic, A. C., Orloff, S. M., Hayden, P. S., Olson, J. M., Schelling, J. R., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000070078.66465.55 · Cited by 72
Mishra, R., & Simonson, M. S. (2005) · Cardiovascular Diabetology · doi:10.1186/1475-2840-4-2 · Cited by 72
Nelson, C. L., Karschimkus, C. S., Dragicevic, G., Packham, D. K., Wilson, A. M., O'Neal, D., Becker, G. J., Best, J. D., & Jenkins, A. J. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi067 · Cited by 64
Cho, W. C. S., Yip, T., Chung, W.-S., Leung, A. W., Cheng, C. H. K., & Yue, K. K. M. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20923 · Cited by 47
Transcriptome Profiling and the Pathogenesis of Diabetic Complications
Connolly, S. B., Sadlier, D. M., Kieran, N. E., Doran, P., & Brady, H. R. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000078022.77369.eb · Cited by 38
Araki, S., Ng, D., Krolewski, B., Wyrwicz, L. S., Rogus, J. J., Canani, L. H. S., Makita, Y., Haneda, M., Warram, J. H., & Królewski, A. S. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000077347.27669.5c · Cited by 35
Nakano, R., Kurosaki, E., Shimaya, A., Kajikawa, S., & Shibasaki, M. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.08.032 · Cited by 12
Statin therapy in patients with chronic kidney disease: to use or not to use
Steinmetz, O. M., Panzer, U., Stahl, R. A. K., & Wenzel, U. O. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01668.x · Cited by 10
Cited by
Leon, B. M. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i13.1246 · Cited by 1,215
Macrophages: versatile players in renal inflammation and fibrosis
Tang, P. M.-K., Nikolic-Paterson, D. J., & Lan, H.-Y. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0110-2 · Cited by 1,033
The Role of Inflammatory Cytokines in Diabetic Nephropathy
Navarro-González, J. F., & Mora-Fernández, C. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007091048 · Cited by 932
Properties of the Glomerular Barrier and Mechanisms of Proteinuria
Haraldsson, B., Nyström, J., & Deen, W. M. (2008) · Physiological Reviews · doi:10.1152/physrev.00055.2006 · Cited by 909
A Glimpse of Various Pathogenetic Mechanisms of Diabetic Nephropathy
Kanwar, Y. S., Sun, L., Xie, P., Liu, F.-Y., & Chen, S. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092150 · Cited by 775
Metadata
- Authors
- Schena, F. P., & Gesualdo, L.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2005-03
- Volume
- 16
- Issue
- 3_suppl_1
- Pages
- S30-S33
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2157002396
- Cited by
- 589
- References
- 45
- FWCI
- 14.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.